Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00246584
Status:
COMPLETED
Last Update Posted:
2006-07-28
First Post:
2005-10-27
Brief Title:
A Long Term Study of SPP100 in Patients With Essential Hypertension Trial is Not Recruiting in the US
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Long-Term Treatment Multicenter Open-Label Study With SPP100 in Patients With Essential Hypertension
Status:
COMPLETED
Status Verified Date:
2006-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the safety and efficacy of long term treatment of SPP100 in patients with essential hypertension Trial is not recruiting in the US
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None